Results 151 to 160 of about 59,358 (257)

MicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis - A functional characterization. [PDF]

Curr Allergy Asthma Rep
Przychodniak D, Jankowski WM, Kurowski M.   +2 more
europepmc   +1 more source

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 226-238, March 2025.
In a study assessing mobile health data, (i) adherence to rhinitis medication was highest for oral antihistamines and lowest for azelastine‐fluticasone, (ii) in weeks of partial adherence, azelastine‐fluticasone was associated with lower levels of reported rhinitis symptoms than other medication classes.
Bernardo Sousa‐Pinto, Elísio M. Costa, Rafael José Vieira, Ludger Klimek, Wienczyslawa Czarlewski, Oliver Pfaar, Anna Bedbrook, Rita Amaral, Luisa Brussino, Violeta Kvedariene, Desiree E. Larenas‐Linnemann, Tomohisa Iinuma, Nhân Pham‐Thi, Frederico S. Regateiro, Luis Taborda‐Barata, Maria Teresa Ventura, Ignacio J. Ansotegui, Karl C. Bergmann, G. Walter Canonica, Victoria Cardona, Lorenzo Cecchi, Ivan Cherrez‐Ojeda, Cemal Cingi, Alvaro A. Cruz, Stefano Del Giacco, Philippe Devillier, Wytske J. Fokkens, Bilun Gemicioglu, Tari Haahtela, Juan Carlos Ivancevich, Piotr Kuna, Helga Kraxner, Daniel Laune, Renaud Louis, Michael Makris, Mario Morais‐Almeida, Ralph Mösges, Marek Niedoszytko, Nikolaos G. Papadopoulos, Vincenzo Patella, Ana Margarida Pereira, Sietze Reitsma, Karla Robles‐Velasco, Philip W. Rouadi, Boleslaw Samolinski, Milan Sova, Sanna K. Toppila‐Salmi, Joaquin Sastre, Arunas Valiulis, Arzu Yorgancioglu, Mihaela Zidarn, Torsten Zuberbier, Joao A. Fonseca, Jean Bousquet, the MASK‐air think tank, Josep M. Anto, Maciej Kupczyk, Marek Kulus, Nicolas Roche, Nicola Scichilone, Rute Almeida, Sinthia Bosnic‐Anticevich, Fulvio Braido, Claudia Chaves Loureiro, Govert de Vries, Antonio F. M. Giuliano, Cristina Jácome, Igor Kaidashev, Gilles Louis, Olga Lourenço, Mika Makela, Marcus Maurer, Joaquim Mullol, Rachel Nadif, Robyn O’Hehir, Yoshitaka Okamoto, Markus Ollert, Heidi Olze, Benoit Pétré, Francesca Puggioni, Jan Romantowski, Daniela Rivero‐Yeverino, Monica Rodriguez‐Gonzalez, Ana Sá‐Sousa, Marine Savouré, Faradiba S. Serpa, Mohamed H. Shamji, Aziz Sheikh, Charlotte Suppli Ulrik, Mikhail Sofiev, Annette Sperl, Ana Todo‐Bom, Ioanna Tsiligianni, Erkka Valovirta, Michiel van Eerd, Hubert Blain, Louis‐Philippe Boulet, Guy Brusselle, Roland Buhl, Denis Charpin, Thomas Casale, Tomas Chivato, Jaime Correia‐de‐Sousa, Christopher Corrigan, Frédéric de Blay, Mark Dykewicz, Alessandro Fiocchi, Mattia Giovannini, Ewa Jassem, Marek Jutel, Thomas Keil, Stefania La Grutta, Brian Lipworth, Alberto Papi, Jean‐Louis Pépin, Santiago Quirce, Carlos Robalo Cordeiro, Maria J. Torres, Omar S. Usmani, Matteo Bonini, Brigita Gradauskiene, Christopher Brightling   +121 more
wiley   +1 more source

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

Clinical &Experimental Allergy, EarlyView.
Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić, Marta Paolucci, Alessandro Streuli, David A. Melillo, Tianchi Jiang, Raffaela Campana, Claudia C. V. Lang, Thomas M. Kündig, Christian Steuer, Klaus Eyer, Pål Johansen   +10 more
wiley   +1 more source

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts. [PDF]

Allergy
Urbano MC, Vieira RJ, Xiang YK, Gil-Mata S, Bedbrook A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Alvarez-Cuesta E, Amade SM, Asllani J, Bennoor KS, Berghea EC, Calvo-Gil M, Caraballo LR, Castro E, Cecchi L, Choudhury D, Christoff G, Chu DK, Cirule I, Cruz AA, Dokic D, Gemicioglu B, Guzman MA, Grisle I, Haahtela T, Hossny E, Hoetzenecker W, Hrubisko M, Iinuma T, Ispayeva Z, Ivancevich JC, Ko FWS, Kraxner H, Kupczyk M, Kvedariene V, Lam Y, Larenas-Linnemann DE, Mahboub B, Mahesh PA, Masjedi MR, McDonald G, Melendez A, Mihaltan F, Milenkovic B, Mohammad Y, Niedoszytko M, O'Hehir RE, Panaitescu C, Panzner P, Papadopoulos NG, Perez JMF, Pham-Thi N, Pitsios C, Plavec D, Repka-Ramirez MS, Romantowski J, Rostan MV, Rottem M, Salim H, Tantilipikorn P, Tomic-Spiric V, Valiulis A, Vecillas LL, Ventura MT, Wallace D, Werminghaus P, Williams S, Zamora FJP, Klimek L, Zuberbier T, Pereira AM, Fonseca JA, Bousquet J, Sousa-Pinto B.   +75 more
europepmc   +1 more source

Matcha alleviates sneezing response in a murine model of allergic rhinitis. [PDF]

NPJ Sci Food
Ogata S, Uda N, Miura K, Enkhbaatar U, Yamasaki N, Hosomi N, Mori A, Hasebe R, Matsuda N, Higashikawa F, Gamboa M, Nakajima S, Kitamura N, Gotoh M, Sekizawa SI, Kaminuma O.   +15 more
europepmc   +1 more source

Spatial transcriptomics identifies fibroblast-T cell crosstalk as a driver of Th2 polarization in allergic rhinitis. [PDF]

Front Immunol
Zhao M, Duan J, Xie Y, Huang G, Yang G, Yang P, Zeng H.   +6 more
europepmc   +1 more source

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, EarlyView.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents-Adherence, rhinitis severity, and asthma onset. [PDF]

Pediatr Allergy Immunol
Hedman AM, Lundholm C, Konradsen JR, Dahl Å, Ingemansson M, Almqvist C.   +5 more
europepmc   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

Clinical &Experimental Allergy, EarlyView.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng, Prawira Oka, Ngiap Chuan Tan   +2 more
wiley   +1 more source

Increased Risk of Allergic Rhinitis Among Coal Mine Workers: A Cross-Sectional Study. [PDF]

Laryngoscope Investig Otolaryngol
Yang X, Wang Z, Yang M, Qing H, Pu X, Gao F, Wang X, Zhang L.   +7 more
europepmc   +1 more source